Compositions and methods for controlling microbial growth

Patent metadata

Field	Value
Publication number	US-10059927-B2
Application number	US-201615000640-A
Country	US
Kind code	B2
Filing date	Jan 19, 2016
Priority date	Jan 19, 2015
Publication date	Aug 28, 2018
Grant date	Aug 28, 2018

Abstract

Provided are modified microorganisms which are modified such that their growth can be controlled using exogenously provided compounds. The microorganisms can be modified by genetic alterations that include a promoter inducible by a first exogenously supplied compound. The promoter can be configured to drive expression of an RNA coding sequence that may be essential to growth of the microorganism. The microorganisms may also be modified to include site specific recombinase recognition sites flanking or within the RNA coding sequence so that expression of the corresponding site specific recombinase will disrupt transcription of the RNA. The site specific recombinase can be configured such that it expression and/or activity is suppressed by a second exogenously supplied compound. Methods of making the modified microorganisms and kits that contain reagents for making and using the modified microorganisms are also provided.

First claim

What is claimed is:

1. A modified microorganism, the growth of which can be controlled by exogenously provided first and second compounds, the modified microorganism having genetic alterations comprising:
i) a promoter inducible by the first compound, wherein the inducible promoter is operably linked to an RNA coding sequence, expression of which is essential for growth of the microorganism, wherein the RNA coding sequence does not encode an auxotrophic marker;
ii) a pair of site specific recombinase recognition sites (SSRRS) flanking or within the RNA coding sequence such that recombination between the SSRRS disrupts expression of the RNA coding sequence; and
iii) a site specific recombinase (SSR) coding region, wherein the SSR is specific for the SSRS, and wherein expression of the SSR is repressed by the second compound,

wherein:
v) the modified microorganism is a pathogenic microorganism, and/or
vi) the modified microorganism further comprises at least one decoy RNA coding sequence or other decoy genetic element introduced into the microorganism, wherein if the decoy RNA coding sequence is present and expressed its expression is not affected by the first or the second compound; and/or
vii) the modified microorganism is in an in vitro culture comprising a culture medium, wherein the culture medium comprises a sub-micromolar concentration of the first and/or second compounds, and wherein the culture medium comprises a greater than sub-micromolar concentration of at least one decoy compound.

2. The modified microorganism of claim 1 , wherein a) the promoter is inducible by a sub-micromolar concentration of the first compound, or b) wherein the expression of the SSR is repressible by or inhibited by a sub-micromolar concentration of the second compound, or both a) and b).

3. The modified microorganism of claim 1 , wherein the modified microorganism has the same or an enhanced growth rate relative to a microorganism of the same type that does not comprise the genetic alterations.

Assignees

• Univ New York
• Univ Johns Hopkins

Inventors

• Boeke Jef D
• Agmon Neta
• Cai Yizhi

Classifications

• C12Y207/07

  Nucleotidyltransferases (2.7.7) · CPC title

• C12N9/1241 Primary

  Nucleotidyltransferases (2.7.7) · CPC title

• C12N2510/00

  Genetically modified cells · CPC title